Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

A new care pathway aims to get cancer surgery patients home safer and faster

NCT ID NCT07727876

Disease control Sponsor: Regional Specialist Hospital in Wroclaw Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time

Summary

This large trial tests whether a structured program called RESET can improve outcomes for adults undergoing planned cancer surgery. RESET combines pre-surgery preparation (prehabilitation), enhanced in-hospital recovery practices, and personalized support after discharge. Researchers will compare patients who receive RESET with those getting standard care to see if it reduces complications, shortens hospital stays, and lowers readmission rates.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a comprehensive perioperative care pathway called RESET that combines prehabilitation, enhanced recovery, and transitional care
What this could lead to
If it works, this could establish a scalable, evidence-based model to improve recovery and reduce hospital stays for cancer surgery patients.
What could go wrong
The program is complex and resource-intensive, so results may vary across hospitals. It is still being tested, so benefits are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 12,800 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Jul 2031

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

ONCOLOGY GROUP Inclusion Criteria: * Age ≥ 18 years * Qualification for admission to surgical departments with an ICD10 diagnosis for radical cancer surgery * Preliminary qualification for one of the procedures listed in Section II.B.23 * Informed consent to participate in the study Exclusion Criteria: * Age \< 18 years * Qualification for admission to surgical departments with an ICD10 diagnosis for diagnostic procedures to identify cancer * Pregnancy or breastfeeding NON-ONCOLOGY GROUP Inclusion Criteria: * Informed consent to participate in the study * Age ≥ 70 years * All consecutive patients referred for planned non-oncological surgical procedures, not solely diagnostic, performed under general anesthesia Exclusion Criteria: \- Diagnosis of cancer

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Frailty are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Frailty neoplasm Postoperative Complications

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Frailty Neoplasms Surgical procedures, operative

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • 4th Military Clinical Hospital in Wroclaw

    RECRUITING

    Wroclaw, Lower Silesian Voivodeship, 50-981, Poland

  • Regional Specialist Hospital in Wrocław

    RECRUITING

    Wroclaw, Lower Silesian Voivodeship, 51-124, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.